申请人:Abbott Laboratories
公开号:US04407803A1
公开(公告)日:1983-10-04
Described are compounds of the formula ##STR1## wherein R.sub.2 -R.sub.8 independently of one another denote hydrogen, loweralkyl, phenyl, alkoxy, halo, hydroxy, nitro, trifluoromethyl, ##STR2## with the proviso that at least one but no more than one of the substituents R.sub.2 -R.sub.8 is ##STR3## and with the further provisos that at least four of the substituents R.sub.2 -R.sub.8 are hydrogen and R.sub.2 cannot be ##STR4## when R.sub.3 -R.sub.8 are hydrogen, and pharmaceutically acceptable salts thereof. The compounds are effective as antiinflammatory and antiasthma agents.
描述了式子##STR1##的化合物,其中R.sub.2-R.sub.8分别独立地表示氢、低碳基、苯基、烷氧基、卤素、羟基、硝基、三氟甲基、##STR2##,但至少一个且不超过一个取代基R.sub.2-R.sub.8是##STR3##,并且进一步规定至少四个取代基R.sub.2-R.sub.8是氢,当R.sub.3-R.sub.8为氢时,R.sub.2不能是##STR4##,以及其药学上可接受的盐。这些化合物对于治疗炎症和哮喘具有有效作用。